Fortress Biotech (FBIO) Share-based Compensation (2010 - 2026)

Fortress Biotech's Share-based Compensation history runs 16 years deep, the most recent figure standing at $2.5 million for Q4 2025.

• In Q4 2025, Share-based Compensation fell 84.81% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $41.7 million (up 43.36% YoY), while the FY2025 annual figure was $28.7 million, down 11.89% from the prior year.
• Share-based Compensation for Q4 2025 stood at $2.5 million, down from $16.8 million in the prior quarter.
• The five-year high for Share-based Compensation was $400.0 million in Q1 2024, with the low at -$12.2 million in Q4 2021.
• The 5-year median for Share-based Compensation is $4.7 million (2023), against an average of $25.5 million.
• The sharpest annual moves came in 2024 and 2025: Share-based Compensation soared 8354.87% in 2024, then slumped 98.43% in 2025.
• Fortress Biotech's Share-based Compensation stood at -$12.2 million in 2021, then soared by 144.98% to $5.5 million in 2022, then slumped by 32.73% to $3.7 million in 2023, then surged by 337.1% to $16.2 million in 2024, then plunged by 84.81% to $2.5 million in 2025.
• Business Quant data shows FBIO's Share-based Compensation at $2.5 million in Q4 2025, $16.8 million in Q2 2025, and $6.3 million in Q1 2025.